SAN DIEGO, July 22 /PRNewswire-FirstCall/ —
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will
report its second quarter 2010 financial results after the Nasdaq
market closes on Wednesday, July 28,
2010. Neurocrine will then host a live
conference call and webcast to discuss its financial results and
provide a Company update Thursday morning, July 29, 2010 at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).
Participants can access the live conference call by dialing
1-800-894-5910, (US) or 785-424-1052 (International) using the
conference ID: 7NBIX. The call can also be accessed via the webcast
through the Company’s website at http://www.neurocrine.com.
If you are unable to attend the webcast and would like
further information on this announcement please contact the
Investor Relations Department at Neurocrine Biosciences at (858)
617-7600. A replay of the Conference Call will be available
approximately one hour after the conclusion of the call by dialing
1-800-753-5207 (US) or 402-220-2156 (International) using the
conference ID: 7NBIX. The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company
focused on neurological and endocrine diseases and disorders. Our
product candidates address some of the largest pharmaceutical
markets in the world including endometriosis, anxiety, depression,